肝移植治疗肝转移癌的临床分析

目的探讨肝移植治疗肝转移癌的可行性和效果。方法4例经病理证实的肝转移癌患者实施了肝移植术，其中胰腺神经内分泌肿瘤肝转移1例．直肠神经内分泌肿瘤肝转移1例，胃间质瘤肝转移1例，结肠癌肝转移1例。手术方式均为经典式原位肝移植术，供体均为尸体供肝。结果4例患者肝移植手术顺利，术后早期恢复好，且生活质量良好。胰腺内分泌肿瘤肝转移患者移植术后4年半，肝脏肿瘤复发，行肝左外叶切除术，至今无瘤生存。直肠神经内分泌肿瘤肝转移患者术后16个月发现右肾及盆腔肿瘤转移．术后5年死于肿瘤复发。胃间质瘤肝转移患者术后5个半月发现盆腔广泛转移，带瘤生存4年半。结肠癌肝转移患者术后3个月双肺广泛转移，术后1年半死亡。结论经...

Full description

Saved in:
Bibliographic Details
Published in中华肿瘤杂志 Vol. 38; no. 5; pp. 381 - 384
Main Author 王连江 张雅敏 邓永林 郑虹 潘澄 沈中阳
Format Journal Article
LanguageChinese
Published 300192,天津市第一中心医院肝胆外科%300192,天津市第一中心医院移植外科 2016
Subjects
肝移植：预后
肿瘤转移
预后
Prognosis
Subject words] Neoplasm metastasis
肝移植
肿瘤转移
Liver transplantation
Online AccessGet full text

Cover

More Information
Summary:目的探讨肝移植治疗肝转移癌的可行性和效果。方法4例经病理证实的肝转移癌患者实施了肝移植术，其中胰腺神经内分泌肿瘤肝转移1例．直肠神经内分泌肿瘤肝转移1例，胃间质瘤肝转移1例，结肠癌肝转移1例。手术方式均为经典式原位肝移植术，供体均为尸体供肝。结果4例患者肝移植手术顺利，术后早期恢复好，且生活质量良好。胰腺内分泌肿瘤肝转移患者移植术后4年半，肝脏肿瘤复发，行肝左外叶切除术，至今无瘤生存。直肠神经内分泌肿瘤肝转移患者术后16个月发现右肾及盆腔肿瘤转移．术后5年死于肿瘤复发。胃间质瘤肝转移患者术后5个半月发现盆腔广泛转移，带瘤生存4年半。结肠癌肝转移患者术后3个月双肺广泛转移，术后1年半死亡。结论经过严格筛选，肝移植可作为部分分化较好的、不能手术切除的肝转移癌患者的一种治疗选择，并可能获得较好的治疗效果。
Bibliography:Neoplasm metastasis ; Liver transplantation ; Prognosis
Wang Lianjiang, Zhang Yamin, Deng Yonglin, Zheng Hong, Pan Cheng, Shen Zhongyang （Department of Hepatobiliary Surgely, Tianjin First Central Hospital, Tianjin 300192, China ; Department of Transplantation, Tianjin First Central Hospital, Tianfin 300192, China ）
11-2152/R
Objective To evaluate the feasibility and outcome of liver transplantation in the treatment of liver metastatic cancer. Methods Four patients with pathologically confirmed liver metastatic cancer underwent liver transplantation, including one of liver metastases from pancreatic endocrine tumor, one from rectal endocrine tumor, one from stomach stromal tumor and one from colorectal carcinoma. Classic surgical method was adopted, i.e. orthotopic liver transplantation for the recipients and transplants came from cadaveric donors. Results All the four patients had a smooth operation, an uneventful early postoperative recovery and good living quality. The patient with liver metastases from pancr
ISSN:0253-3766
DOI:10.3760/cma.j.issn.0253-3766.2016.05.012